American Society of Hematology

06/23/2026

One platform. Endless genomic insights. 🧬

ASH HematOmics (ASHOP) gives researchers and clinicians access to comprehensive genomic data to help uncover therapeutic targets, investigate clinical correlations, and advance discovery across blood diseases.

What makes ASHOP different?

💻 Integrates comprehensive genomic data from world-class institutions
📋 Enables variant exploration and clinical interpretation
🌐 Features intuitive web-based visualization tools
🔍 Supports therapeutic target discovery across hematologic diseases

Learn more: https://ow.ly/BLcy50ZfK8q

06/23/2026

ASH is proud to honor 11 distinguished hematologists with its most prestigious awards and named lectures, recognizing transformative contributions that have advanced research, patient care, and education in blood diseases.

👏 Congratulations to all!

🔗 Read about the recipients in the press release: https://ow.ly/jO6O50ZfSiR

06/23/2026

06/22/2026

🚨 Last chance: ASH CRTI applications are closing soon!

Fellows and early- to mid-career faculty across Latin America, Asia-Pacific, and the Middle East and North Africa are encouraged to apply for this in-person program focused on clinical trial design, patient-oriented research, mentorship, and leadership development.

📅 Deadline: June 24, 2026 by 11:59 PM Eastern Time

Don’t miss out. Apply today! https://ow.ly/4b0750Zfmgv

06/21/2026

ASH continues to engage with the National Institutes of Health (NIH) on the development of its FY27–FY31 Strategic Plan, emphasizing the critical role of hematology research and care across NIH priorities. In its response to the Request for Information (RFI), ASH highlighted key priorities from the ASH Agenda for Hematology Research, including:

▪️Precision medicine

▪️Immunotherapy

▪️Gene editing & stem cells

▪️Thrombosis & infection research

These priorities are intended to help inform NIH’s future strategic direction and accelerate advances in hematologic research and patient care.

Read ASH’s request: https://ow.ly/PN1U50Zeq0i

06/21/2026

Your science. Your voice. Your moment.

The abstract submission portal for the 68th ASH Annual Meeting and Exposition is officially OPEN.

Join thousands of scientists and clinicians this December and contribute to one of the most anticipated gatherings in .

Submit your abstract today: https://ow.ly/XI3O50ZepU1

06/20/2026

You can make a difference for people living with sickle cell disease.

The ASH Foundation’s Sickle Cell Disease Initiative Fund supports research, education, advocacy, and programs like the Consortium on Newborn Screening in Africa (CONSA).

Start a personal fundraiser in just a few minutes:

🩺 Share your story

🎯 Set a goal

💌 Ask friends and family to give

Every dollar helps move closer to earlier diagnosis, better treatment, and stronger support for the SCD community.

Start your fundraiser today: https://ow.ly/CZch50ZcPav

06/19/2026

Today is World Sickle Cell Disease Day.

SCD is the world's most common inherited blood disorder, affecting an estimated 7.75 million people globally and 515,000 newborns each year. Nearly 80% of cases occur in sub-Saharan Africa, where access to screening and lifesaving interventions remains limited.

Through the Consortium on Newborn Screening in Africa (CONSA), ASH has supported newborn screening and clinical capacity-building efforts in seven countries across sub-Saharan Africa. To date, CONSA has screened more than 200,000 newborns for sickle cell disease, helping connect infants and families to early diagnosis and care. Donations to the ASH Foundation have also helped advance SCD awareness, education, and care.

Together, these efforts are helping improve outcomes for individuals and families affected by sickle cell disease worldwide.

Support CONSA and the future of sickle cell care by donating to the ASH Sickle Cell Disease Initiative Fund: https://ow.ly/aKRT50ZeeHM

06/18/2026

Early recognition can change outcomes for patients with AL amyloidosis.

In the latest HemeTalks episode, Dr. Sai Jambunathan shares her personal experience navigating diagnosis, treatment, and life with this rare blood disorder.

Tune in to:

✔️ Learn how AL amyloidosis can present with subtle, nonspecific symptoms that make early diagnosis challenging

✔️ Hear why clear, compassionate communication from the care team can make a meaningful difference for patients and families

✔️ Discover how community, advocacy, and peer support can help patients navigate a rare disease journey

Listen now: https://ow.ly/kzu650Zcfiv

ASH Education

06/18/2026

🩸 Stronger laboratories mean faster diagnoses and better outcomes for children with sickle cell disease.

With support from the ASH Foundation, at the 2026 CONSA Laboratory Summit, more than 35 laboratory professionals, clinicians, and stakeholders from across the seven CONSA countries came together to share best practices in newborn screening, explore emerging technologies, and strengthen the quality of sickle cell disease diagnosis. The former Minister of Health of Uganda also joined the meetings and expressed support for efforts to expand newborn screening for sickle cell disease.

The summit provided an opportunity for participants to exchange knowledge, address common challenges, and collaborate on strategies to improve laboratory systems and diagnostic capacity for sickle cell disease across sub-Saharan Africa. By investing in training, innovation, and regional collaboration, CONSA is helping expand access to early diagnosis and connect more children and families to timely, lifesaving care.



Support CONSA through the ASH Foundation:
https://ow.ly/MOql50ZcNIz